|
Ichim has served a variety of instrumental roles for companies operating in the area of biologics. He obtained numerous regulatory approvals for companies such as MarrowTech Pharma, and worked as a Program Director for the global CRO bioRASI, under which he led efforts to develop, clinically assess, and approve various stem cell and cellular therapies. Ichim has also founded two companies, ToleroTech Inc. and MedVax Pharma Corp., which are developing proprietary technologies in the areas of RNA interference and cancer vaccines, respectively. Ichim is an accomplished scientist with 15 scientific papers published in areas ranging from immunological tolerance, to cancer therapy, to autoimmunity. Additionally Ichim has numerous patents filed and issued covering diverse topics. | 